Press Releases
January 18, 2026
U.S., Taiwan Seal USD500B Semiconductor Agreement
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
January 17, 2026
US–Taiwan Semiconductor Pact Signals Massive Investment
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
January 20, 2026
Avalue Technology Launches the BMX Series Industrial Barebone Systems
Neutral
EIN Presswire
January 20, 2026
Dispatch from Guangzhou: Stabilizing US-China Relations in the Arctic
Indeterminate
The Arctic Institute
Owner: The Arctic Institute (Non-profit)
January 20, 2026
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)
Indeterminate
GlobeNewswire, Inc.
January 14, 2026
CE meets Minister of National Health Commission to deepen healthcare cooperation
Gov't Institution
Macao Government News
Owner: Macau Government
January 14, 2026
NFT in Healthcare Market Forecasts From USD 250 Mn in 2025 to USD 1,142.77 Mn by 2034 - Trends, Drivers & Strategic Outlook
Indeterminate
GlobeNewswire, Inc.
January 20, 2026
Radware Launches a New End-to-End API Security Service Delivering Runtime Protection and Posture Management of APIs
Indeterminate
GlobeNewswire, Inc.
January 8, 2026
Deloitte Taiwan and C2A Security Partner to Accelerate Innovation in Product Security and Risk Management
Neutral
EIN Presswire
January 7, 2026
OTC Markets Group Welcomes Bora Pharmaceuticals Co., Ltd. to OTCQX
Indeterminate
GlobeNewswire, Inc.
January 5, 2026
Why Respiratory Vaccines Remain a Strategic Focus for Healthcare Systems Worldwide?
Indeterminate
GlobeNewswire, Inc.
December 31, 2025
The Weaver Launches its "Seven-Country Wellness Village Project" from Taiwan
Indeterminate
GlobeNewswire, Inc.
January 1, 2026
Premio Inc. (United States) and C&T Solution Inc. (Taiwan) Consolidate Under One Brand to Advance Edge AI Leadership
Neutral
EIN Presswire
January 19, 2026
Sustainable Wipe Packaging Market Research Report 2026-35
Indeterminate
GlobeNewswire, Inc.
December 23, 2025
The End Brain Cancer Initiative Shares PCNSL Patient Friendly Resource About ONO PHARMA Phase II PROSPECT Study Results
Neutral
EIN Presswire